+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hypertrophic and Keloid Scar Treatment - Global Market Trajectory & Analytics

  • ID: 5303450
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Cynosure, Inc
  • Enaltus, LLC
  • Lumenis
  • Merz, Inc
  • Mölnlycke Health Care AB
  • Pacific World Corporation
Global Hypertrophic and Keloid Scar Treatment Market to Reach $11 Billion by 2027

Amid the COVID-19 crisis, the global market for Hypertrophic and Keloid Scar Treatment estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$11 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. Topical, one of the segments analyzed in the report, is projected to record a 8.6% CAGR and reach US$5.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laser segment is readjusted to a revised 9% CAGR for the next 7-year period.





The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 13% CAGR

The Hypertrophic and Keloid Scar Treatment market in the U.S. is estimated at US$1.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2027 trailing a CAGR of 12.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 7.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Injectable Segment to Record 8% CAGR

In the global Injectable segment, USA, Canada, Japan, China and Europe will drive the 7.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$689.8 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.5 Billion by the year 2027, while Latin America will expand at a 9.4% CAGR through the analysis period.

Select Competitors (Total 43 Featured):
  • Cynosure, Inc
  • Enaltus, LLC
  • Lumenis
  • Merz, Inc
  • Mölnlycke Health Care AB
  • NewMedical Technology, Inc
  • Pacific World Corporation
  • Perrigo Company plc
  • Scar Heal, Inc
  • Smith & Nephew PLC
  • Sonoma Pharmaceuticals
  • Suneva Medical, Inc
Frequently Asked Questions about the Global Market for Hypertrophic and Keloid Scar Treatment

What is the estimated value of the Global Market for Hypertrophic and Keloid Scar Treatment?

The Global Market for Hypertrophic and Keloid Scar Treatment was estimated to be valued at $6.2 Billion in 2020.

What is the growth rate of the Global Market for Hypertrophic and Keloid Scar Treatment?

The growth rate of the Global Market for Hypertrophic and Keloid Scar Treatment is 8.5%, with an estimated value of $11.0 Billion by 2027.

What is the forecasted size of the Global Market for Hypertrophic and Keloid Scar Treatment?

The Global Market for Hypertrophic and Keloid Scar Treatment is estimated to be worth $11.0 Billion by 2027.

Who are the key companies in the Global Market for Hypertrophic and Keloid Scar Treatment?

Key companies in the Global Market for Hypertrophic and Keloid Scar Treatment include Cynosure, Inc, Enaltus, LLC, Lumenis, Merz, Inc, Mölnlycke Health Care AB, NewMedical Technology, Inc, Pacific World Corporation, Perrigo Company plc and Smith & Nephew PLC.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cynosure, Inc
  • Enaltus, LLC
  • Lumenis
  • Merz, Inc
  • Mölnlycke Health Care AB
  • Pacific World Corporation

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION
  • Total Companies Profiled: 43
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Cynosure, Inc
  • Enaltus, LLC
  • Lumenis
  • Merz, Inc
  • Mölnlycke Health Care AB
  • NewMedical Technology, Inc
  • Pacific World Corporation
  • Perrigo Company plc
  • Scar Heal, Inc
  • Smith & Nephew PLC
  • Sonoma Pharmaceuticals
  • Suneva Medical, Inc
Note: Product cover images may vary from those shown